SCHEMBL6600737

SCHEMBL6600737

COc1ccc(C2=NN(C(=O)c3ccc(NC(=O)c4ccco4)cc3)CCC2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.54
TSHR P16473 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
MAPK1 P28482 1/20 0.54
CYP2C19 P33261 1/20 0.54
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
MAPT P10636 4/20 0.49
HPGD P15428 3/20 0.49
POLB P06746 2/20 0.49
KMT2A Q03164 4/20 0.48
RAB9A P51151 3/20 0.48
MEN1 O00255 3/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 2/20 0.48
TP53 P04637 2/20 0.48
ESR1 P03372 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6601909 0.94 MAPT (0.52) NPSR1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL6604786 0.93 TSHR (0.47) NPSR1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL6601043 0.92 TSHR (0.49) NPSR1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL6601154 0.92 SMN1; SMN2 (0.50) NPSR1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL6606068 0.90 HTT (0.46) NPSR1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL6601439 0.86 MAOB (0.47) TSHRMAPK1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6605494 0.86 MAPT (0.51) NPSR1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL6605631 0.85 NPSR1 (0.52) NPSR1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL6604008 0.85 ALDH1A1 (0.51) CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL6601921 0.84 MAOB (0.57) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed